●2008年業績集［原著］
1. Akiba T, Akizawa T, Tsukamoto Y, Uchida E, Iwasaki M, Koshikawa S. Dose determination of cinacalcet hydrochloride inJapanese hemodialysis patients with secondary hyperparathyroidism. Ther. Apher. Dial. 12:117‒25, 2008.
2. Chiga M, Rai T, Yang SS, Ohta A, Takizawa T, Sasaki S, Uchida S. Dietary salt regulates the phosphorylation ofOSR1/SPAK kinases and the sodium chloride cotransporter through aldosterone. Kidney Int. 74:1403‒9, 2008.
3. Fujii H, Mori Y, Kayamori K, Igari T, Ito E, Akashi T, Noguchi Y, Kitamura K, Okado T, Terada Y, Kanda E, Rai T, Uchida S,Sasaki S. A familial case of mitochondrial disease resembling Alport syndrome. Clin. Exp. Nephrol. 12:159‒63, 2008.
4. Fujimoto M, Imai K, Hirata K, Kashiwagi R, Morinishi Y, Kitazawa K, Sasaki S, Arinami T, Nonoyama S, Noguchi E.
Immunological proﬁle in a family with nephrogenic diabetes insipidus with a novel 11 kb deletion in AVPR2 and ARHGAP4
genes. BMC Med. Genet. 9:42, 2008.
5. Fukagawa M, Yumita S, Akizawa T, Uchida E, Tsukamoto Y, Iwasaki M, Koshikawa S. Cinacalcet (KRN1493) eﬀectively
decreases the serum intact PTH level with favorable control of the serum phosphorus and calcium levels in Japanese
dialysis patients. Nephrol. Dial. Transplant. 23:328‒35, 2008.
6. Ito K, Ozasa H, Noda Y, Koike K, Arii S, Horikawa S. Eﬀect of non‒essential amino acid glycine administration on the liver
regeneration of partially hepatectomized rats with hepatic ischemia/reperfusion injury. Clin. Nutr. 27:773‒780, 2008.
7. Ito K, Ozasa H, Noda Y, Arii S, Horikawa S. Eﬀects of free radical scavenger on acute liver injury induced by D‒
galactosamine and lipopolysaccharide in rats. Hepatol. Res. 38:194‒201, 2008.
8. Kobayashi T, Terada Y, Kuwana H, Tanaka H, Okado T, Kuwahara M, Tohda S, Sakano S, Sasaki S. Expression and functionof the Delta‒1/Notch‒2/Hes‒1 pathway during experimental acute kidney injury. Kidney Int. 73:1240‒50, 2008.
9. Kuwana H, Terada Y, Kobayashi T, Okado T, Penninger JM, Irie‒Sasaki J, Sasaki T, Sasaki S. The phosphoinositide‒3 kinasegamma‒Akt pathway mediates renal tubular injury in cisplatin nephrotoxicity. Kidney Int. 73:430‒445, 2008.
10. Hayakawa S, Mori M, Okuta A, Kamegawa A, Fujiyoshi Y, Yoshiyama Y, Mitsuoka K, Ishibashi K, Sasaki S, Hattori T,Kuwabara S. Neuromyelitis optica and anti‒aquaporin‒4 antibodies measured by an enzyme‒linked immunosorbent assay. J.
Neuroimmunol. 196:181‒187, 2008.
11. Maeda Y, Inaba N, Aoyagi M, Tanase T, and Shiigai T. Pseudoaldosteronism caused by combined administration ofcilostazol and glycyrrhizin. Intern. Med. 47:1345‒ 1348, 2008.
12. Noda Y, Horikawa S, Kanda E, Yamashita M, Meng H, Eto E, Li Y, Kuwahara M, Hirai K, Pack C, Kinjo M, Okabe S, Sasaki
S. Reciprocal interaction with G‒actin and tropomyosin is essential for aquaporin‒2 traﬃcking. J. Cell Biol. 182:587‒601,
2008.
13. Okada S, Misaka T, Tanaka Y, Matsumoto I, Ishibashi K, Sasaki S, Abe K. Aquaporin‒11 knockout mice and polycystic
kidney disease animals share a common mechanism of cyst formation. FASEB J . 22:3672‒3684, 2008.
14. Okamoto F, Kajiya H, Toh K, Uchida S, Yoshikawa M, Sasaki S, Kido MA, Tanaka T, Okabe K. Intracellular ClC‒3 chloride
channels promote bone resorption in vitro through organelle acidiﬁcation in mouse osteoclasts. Am. J .Physiol. Cell Physiol.
294:C693‒701, 2008.
15. Okutsu R, Rai T, Kikuchi A, Ohno M, Uchida K, Sasaki S, Uchida S. AKAP220 colocalizes with AQP2 in the inner
medullary collecting ducts. Kidney Int. 74:1429‒33, 2008.
16. Saito T, Saito T, Kasono K, Tamemoto H, Kawakami M, Sasaki S, Ishikawa SE. Hypotonicity reduces the activity of murineaquaporin‒2 promoter induced by dibutyryl cAMP. Exp. Physiol. 93:1147‒56, 2008.
17. Shigematsu T, Akizawa T, Uchida E, Tsukamoto Y, Iwasaki M, Koshikawa S. Long‒term cinacalcet HCl treatment improvedbone metabolism in Japanese hemodialysis patients with secondary hyperparathyroidism. Am. J. Nephrol. 29:230‒6, 2008.

18. Sohara E, Luo Y, Zhang J, Manning DK, Beier DR, Zhou J. Nek8 regulates the expression and localization of polycystin‒1and polycystin‒2. J . Am. Soc .Nephrol. 19:469‒76, 2008.
19. Takeda A, Toda T, Iwamoto H, Watanabe K, Matsui N．Long‒term evaluation and changing associations of left
ventricular hypertrophy after starting hemodialysis. Nephron Clin. Pract. 110:126‒132, 2008.
20. Tchekneva EE, Khuchua Z, Davis LS, Kadkina V, Dunn SR, Bachman S, Ishibashi K, Rinchik EM, Harris RC, Dikov MM,Breyer MD. Single amino acid substitution in aquaporin 11 causes renal failure. J. Am. Soc. Nephrol. 19:1955‒1964, 2008.
21. Terada Y, Kuwana H, Kobayashi T, Okado T, Suzuki N, Yoshimoto T, Hirata Y, Sasaki S. Aldosterone‒stimulated SGK1
activity mediates proﬁbrotic signaling in the mesangium. J. Am. Soc. Nephrol. 19:298‒309, 2008.
22. Tsukamoto Y. End‒stage renal disease (ESRD) and its treatment in Japan. Nephrol. Dial. Transplant. 23:2447‒50, 2008.
23. Yajima A, Akizawa T, Tsukamoto Y, Kurihara S, Ito A. Impact of cinacalcet hydrochloride on bone histology in patientswith secondary hyperparathyroidism. Ther. Apher. Dial. Oct;12 Suppl 1:S38‒43, 2008.
24. Wada K and Shinoda T. A case report of an anorexia nervosa patient with end‒stage renal disease due to pseudo
Bartter’s syndrome and Chinese herb nephropathy requiring maintenance hemodialysis. Ther. Apher. Dial. 12: 417‒420,
2008.